Ubikare
PrivateLast Round
Grant
Jan 28, 2022
Total Funding Raised
$1.63M
Company Overview
Ubikare is a health-tech company that develops modular software solutions and the NAIHA (Natural & Artificial Intelligence Health Assistant) platform to optimize management and care in the healthcare and socio-health sectors.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Clinical Trials, EHR & EMR, Quantum Computing
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ubikare Comparables
Compare Ubikare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dassault Systèmes | 68% | |
| Veeva Systems | 65% | |
| Castor | 64% |
Ubikare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 28, 2022 | ||||
| Corporate Funding | Sep 21, 2021 | ||||
| Seed | Jul 14, 2020 | ||||
| Seed | Jan 8, 2020 |
Ubikare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seed Capital Bizkaia | Seed |
| Mutua Ventures | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Partnered with Vicomtech and Multiverse Computing on Q-CLINIC initiative.
- Apr 14, 2026
Launched Q-CLINIC, applying quantum algorithms to clinical data management.
Ubikare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ubikare's valuation, stock price, and market status.
Is Ubikare a public or private company?
Ubikare is a private company.
What is the current stock price of Ubikare?
Ubikare is a private company, so its shares have no public market price. Caplight tracks Ubikare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ubikare worth (valuation)?
Valuation information for Ubikare is not publicly available.
Can I buy Ubikare stock?
Ubikare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ubikare's last funding round?
Ubikare's most recent funding round was Grant on January 28, 2022.
Who are the main investors in Ubikare?
Key investors in Ubikare include Seed Capital Bizkaia, Mutua Ventures.
Will Ubikare IPO soon?
No public IPO plans have been announced for Ubikare.
How can I track Ubikare secondary market activity?
Caplight tracks bids, offers, and trades in Ubikare's shares on secondary markets.